| For: | Wagner S, Mullins CS, Linnebacher M. Colorectal cancer vaccines: Tumor-associated antigens vs neoantigens. World J Gastroenterol 2018; 24(48): 5418-5432 [PMID: 30622371 DOI: 10.3748/wjg.v24.i48.5418] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v24/i48/5418.htm |
| Number | Citing Articles |
| 1 |
Peiwei Sun, Luolin Wang, Zhong Liu, Zhenglei Xu. Design and immunogenic evaluation of multi-epitope vaccines for colorectal cancer: insights from molecular dynamics and In-Vitro studies. Frontiers in Oncology 2025; 15 doi: 10.3389/fonc.2025.1592072
|
| 2 |
Han Lin, Kun Wang, Yuxin Xiong, Liting Zhou, Yong Yang, Shanwei Chen, Peihong Xu, Yujun Zhou, Rui Mao, Guangzhao Lv, Peng Wang, Dong Zhou. Identification of Tumor Antigens and Immune Subtypes of Glioblastoma for mRNA Vaccine Development. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.773264
|
| 3 |
Chengyi Li, Fang Ke, Shuai Mao, Zera Montemayor, Mohamed Dit Mady Traore, Alejandra Duran Balsa, Mahamadou Djibo, Neha Karekar, Hongxiang Hu, Hanning Wen, Wei Gao, Duxin Sun. SARS-CoV-2 B Epitope-Guided Neoantigen NanoVaccines Enhance Tumor-Specific CD4/CD8 T Cell Immunity through B Cell Antigen Presentation. ACS Nano 2025; 19(7) doi: 10.1021/acsnano.4c15113
|
| 4 |
Chanchal Kumar, Rajat Pratap Singh, Mrigendra Kumar Dwiwedi, Ajay Amit. Colon Cancer Diagnosis and Therapy. 2021; doi: 10.1007/978-3-030-63369-1_14
|
| 5 |
Gary A. Piazza, Preethi Chandrasekaran, Yulia Y. Maxuitenko, Karim I. Budhwani. Assessment of KRASG12C inhibitors for colorectal cancer. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1412435
|
| 6 |
Lena Pfitzer, Gitta Boons, Lien Lybaert, Wim van Criekinge, Cedric Bogaert, Bruno Fant. Accelerating Neoantigen Discovery: A High-Throughput Approach to Immunogenic Target Identification. Vaccines 2025; 13(8) doi: 10.3390/vaccines13080865
|
| 7 |
Sanjoy Majumder, Gagan Kumar Panigrahi, Annapurna Sahoo. Nonsense-mediated mRNA decay as a gatekeeper of neoantigen expression: Bridging RNA surveillance and tumor immunotherapy. Molecular Biology Reports 2026; 53(1) doi: 10.1007/s11033-026-12371-z
|
| 8 |
. 2022; doi: 10.70675/c94ffad0z611fz4291za852z2bae9e05047b
|
| 9 |
Kangchan Choi, Do Hyun Lee, Ji Won Lee, Yong Serk Park. Advancements in Cancer Immunotherapy: The Evolution and Future of mRNA and DNA Vaccine Technologies. Biomedical Science Letters 2025; 31(1) doi: 10.15616/BSL.2025.31.1.1
|
| 10 |
Shu-Chang Nie, Yan-Hua Jing, Lu Lu, Si-Si Ren, Guang Ji, Han-Chen Xu. Mechanisms of myeloid-derived suppressor cell-mediated immunosuppression in colorectal cancer and related therapies. World Journal of Gastrointestinal Oncology 2024; 16(5): 1690-1704 doi: 10.4251/wjgo.v16.i5.1690
|
| 11 |
Thangavelu Soundara Rajan, Agnese Gugliandolo, Placido Bramanti, Emanuela Mazzon. In Vitro-Transcribed mRNA Chimeric Antigen Receptor T Cell (IVT mRNA CAR T) Therapy in Hematologic and Solid Tumor Management: A Preclinical Update. International Journal of Molecular Sciences 2020; 21(18) doi: 10.3390/ijms21186514
|
| 12 |
Boya Peng, Migara Kavishka Jayasinghe, Anh Hong Le, Nhut Minh Tran, Minh T.N. Le. Designing nucleic acid-based therapeutics for cancer treatment: Updates on the state of the art. Molecular Therapy 2026; 34(1) doi: 10.1016/j.ymthe.2025.09.041
|
| 13 |
. 2024; doi: 10.70675/debbeaf5za078z42b2z8d08z38fb615e6ddd
|
| 14 |
Jianshuang Ma, Congming Xiang, Dong Xia. Colorectal cancer and tumor vaccines (Review). Oncology Letters 2026; 32(4) doi: 10.3892/ol.2026.15827
|
| 15 |
Megen C. Wittling, Amalia M. Rivera-Reyes, Megan M. Wyatt, Anna C. Cole, Aubrey S. Smith, Guillermo O. Rangel Rivera, James H. Carmouche, Kailey G. Diatikar, Ayana T. Ruffin, Michael B. Ware, Frances J. Bennett, Connor J. Dwyer, Riley M.F. Pihl, Soundharya Kumaresan, Gregory B. Lesinski, Chrystal M. Paulos, Hannah M. Knochelmann. T-cell Priming by High-Avidity Neoantigens in Lymph Nodes Augments Adoptive Immunotherapy. Cancer Immunology Research 2026; 14(3) doi: 10.1158/2326-6066.CIR-25-0514
|
| 16 |
Zhi-Hong CHEN, Yue WANG, Jian MA. The role of CD4<sup>+</sup> T cells in colorectal tumors and research progress on targeting CD4<sup>+</sup> T cells for antitumor strategies. Chinese Bulletin of Life Sciences 2026; 38(4) doi: 10.3724/cbls.2026072
|
| 17 |
Chenxiao Liu, Nan Liu, Tongcun Zhang, Yanyang Tu. Adoptive immune cell therapy for colorectal cancer. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1557906
|
| 18 |
Ya‐Juan Zhu, Xiong Li, Ting‐Ting Chen, Jia‐Xiang Wang, Yi‐Xin Zhou, Xiao‐Li Mu, Yang Du, Jia‐Ling Wang, Jie Tang, Ji‐Yan Liu. Personalised neoantigen‐based therapy in colorectal cancer. Clinical and Translational Medicine 2023; 13(11) doi: 10.1002/ctm2.1461
|
| 19 |
Anil Kumar, Vipasha Gautam, Arushi Sandhu, Kajal Rawat, Antika Sharma, Lekha Saha. Current and emerging therapeutic approaches for colorectal cancer: A comprehensive review. World Journal of Gastrointestinal Surgery 2023; 15(4): 495-519 doi: 10.4240/wjgs.v15.i4.495
|
| 20 |
Zhikui Huo, Guoliang Liu, Jiannan Li. Recent research progress and clinical status of immunotherapy for colorectal cancer. Journal of Advanced Research 2026; 82 doi: 10.1016/j.jare.2025.06.089
|
| 21 |
Klaudia Kiel, Raziye Piranlioglu, Jakub Godlewski, Agnieszka Bronisz. Harnessing immunotherapy: cancer vaccines as novel therapeutic strategies for brain tumor. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1588081
|
| 22 |
Simon N. Mbugua, Lydia W. Njenga, Ruth A. Odhiambo, Shem O. Wandiga, Martin O. Onani. Beyond DNA-targeting in Cancer Chemotherapy. Emerging Frontiers - A Review. Current Topics in Medicinal Chemistry 2021; 21(1) doi: 10.2174/1568026620666200819160213
|
| 23 |
Stephen Jiang, David Good, Ming Q. Wei. Vaccinations for Colorectal Cancer: Progress, Strategies, and Novel Adjuvants. International Journal of Molecular Sciences 2019; 20(14) doi: 10.3390/ijms20143403
|
| 24 |
Ajay Prakash, Travis Gates, Xianda Zhao, Dechen Wangmo, Subbaya Subramanian. Tumor-derived extracellular vesicles in the colorectal cancer immune environment and immunotherapy. Pharmacology & Therapeutics 2023; 241 doi: 10.1016/j.pharmthera.2022.108332
|
| 25 |
Rajeev Ranjan, Amit Kumar, Vikas Kumar, Bhawesh Kumar Mahato, Atreyee Sarkar, Ratnesh Kumar Yadav, Vikas Gond, Sreeharsha Nagaraja, Ravi Raj Pal. Emerging Immunotherapeutic Approaches in Colorectal Cancer: From Checkpoint Inhibitors to CAR-T Cell and Viral Vector Vaccines. Immunological Investigations 2026; 55(3) doi: 10.1080/08820139.2026.2613047
|
| 26 |
Elżbieta Chruściel, Zuzanna Urban-Wójciuk, Łukasz Arcimowicz, Małgorzata Kurkowiak, Jacek Kowalski, Mateusz Gliwiński, Tomasz Marjański, Witold Rzyman, Wojciech Biernat, Rafał Dziadziuszko, Carla Montesano, Roberta Bernardini, Natalia Marek-Trzonkowska. Adoptive Cell Therapy—Harnessing Antigen-Specific T Cells to Target Solid Tumours. Cancers 2020; 12(3) doi: 10.3390/cancers12030683
|
| 27 |
Rong Jiao, Xia Lin, Qian Zhang, Yan Zhang, Wen Qin, Qiaoling Yang, Chuan Xu, Fubo Chen, Kun Zhang. Anti-tumor immune potentiation targets-engineered nanobiotechnologies: Design principles and applications. Progress in Materials Science 2024; 142 doi: 10.1016/j.pmatsci.2023.101230
|
| 28 |
Lei Du, Qi Cheng, Hao Zheng, Jinming Liu, Lei Liu, Quan Chen. Targeting stemness of cancer stem cells to fight colorectal cancers. Seminars in Cancer Biology 2022; 82 doi: 10.1016/j.semcancer.2021.02.012
|
| 29 |
Xiaoxue Xie, Ting Song, Yi Feng, Hanxi Zhang, Geng Yang, Chunhui Wu, Fengming You, Yiyao Liu, Hong Yang. Nanotechnology-based multifunctional vaccines for cancer immunotherapy. Chemical Engineering Journal 2022; 437 doi: 10.1016/j.cej.2022.135505
|
| 30 |
Rani Chudasama, Quan Phung, Andrew Hsu, Khaldoun Almhanna. Vaccines in Gastrointestinal Malignancies: From Prevention to Treatment. Vaccines 2021; 9(6) doi: 10.3390/vaccines9060647
|
| 31 |
Sajid Muhammad, Bing Li, Wenda Zhong, Hina Siddiqui, Yufen Zhao, Jinhui Wang. AI-enhanced synergistic chemo-immunotherapy: From mechanistic insights to clinical translation. Critical Reviews in Oncology/Hematology 2026; 217 doi: 10.1016/j.critrevonc.2025.105064
|
| 32 |
Husham O Elzein. Association of Leukemia With ABO Blood Group Distribution and Discrepancy: A Review Article. Cureus 2024; doi: 10.7759/cureus.56812
|
| 33 |
Suman K. Ray, Yamini Meshram, Sukhes Mukherjee. Cancer Immunology and CAR-T Cells: A Turning Point Therapeutic Approach in Colorectal Carcinoma with Clinical Insight. Current Molecular Medicine 2021; 21(3) doi: 10.2174/1566524020666200824103749
|
| 34 |
Nurul Ainaa Adilah Rus Bakarurraini, Nurul Syakima Ab Mutalib, Rahman Jamal, Nadiah Abu. The Landscape of Tumor-Specific Antigens in Colorectal Cancer. Vaccines 2020; 8(3) doi: 10.3390/vaccines8030371
|
| 35 |
Kishwor Poudel, Tulasi Vithiananthan, Jong Oh Kim, Hensin Tsao. Recent progress in cancer vaccines and nanovaccines. Biomaterials 2025; 314 doi: 10.1016/j.biomaterials.2024.122856
|
| 36 |
Danyang Wang, Hangyu Zhang, Tao Xiang, Gang Wang. Clinical Application of Adaptive Immune Therapy in MSS Colorectal Cancer Patients. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.762341
|
| 37 |
Julieann Puleo, Kornelia Polyak. A Darwinian perspective on tumor immune evasion. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2022; 1877(1) doi: 10.1016/j.bbcan.2021.188671
|
| 38 |
Wenqing Jia, Tao Zhang, Haiyan Huang, Haoran Feng, Shaodong Wang, Zichao Guo, Zhiping Luo, Xiaopin Ji, Xi Cheng, Ren Zhao. Colorectal cancer vaccines: The current scenario and future prospects. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.942235
|
| 39 |
Georgios M. Stergiopoulos, Ianko Iankov, Evanthia Galanis. Personalizing Oncolytic Immunovirotherapy Approaches. Molecular Diagnosis & Therapy 2024; 28(2) doi: 10.1007/s40291-023-00689-4
|
| 40 |
Bhawana Yadav, Shiva Prasad Kollur, Amena Ali, Payas Arora, Aanika Gupta, P. Saranraj, Vijay Jagdish Upadhye, Pallavi Singh. Peptides as integrative modulators for clinical prognosis and targeted therapy in pancreatic cancer. Discover Oncology 2026; 17(1) doi: 10.1007/s12672-026-05130-w
|
| 41 |
Jianpei Hu, Zengnan Mo. Dissection of tumor antigens and immune landscape in clear cell renal cell carcinoma: Preconditions for development and precision medicine of mRNA vaccine. Mathematical Biosciences and Engineering 2022; 20(2) doi: 10.3934/mbe.2023100
|
| 42 |
Hairuo Huang, Jianmin Ren, Deming Jiang, Shurong Hu, Qiao Yu, Bufu Tang, Pingbo Xu, Jingwen Liu. Breaking barriers in CRC immunotherapy: Cutting-edge advances in personalized peptide vaccine development. Critical Reviews in Oncology/Hematology 2025; 216 doi: 10.1016/j.critrevonc.2025.104967
|
| 43 |
Mina Shahnazari, Pouria Samadi, Mona Pourjafar, Akram Jalali. Therapeutic vaccines for colorectal cancer: The progress and future prospect. International Immunopharmacology 2020; 88 doi: 10.1016/j.intimp.2020.106944
|
| 44 |
Sabrina Brigitta Valerie Setiono, Grace Lendawati Amelia Turalaki, Trina Ekawati Tallei. The Evolving Landscape of the Colorectal Cancer Vaccines: From Biological Mechanisms to Translational Therapeutics. Heca Journal of Applied Sciences 2026; 4(1) doi: 10.60084/hjas.v4i1.372
|
| 45 |
Peter G. Alexander, Donald C. McMillan, James H. Park. The local inflammatory response in colorectal cancer – Type, location or density? A systematic review and meta-analysis. Cancer Treatment Reviews 2020; 83 doi: 10.1016/j.ctrv.2019.101949
|
| 46 |
Caitlin Boyne, Debra Lennox, Olivia Beech, Simon J. Powis, Pankaj Kumar. What Is the Role of HLA-I on Cancer Derived Extracellular Vesicles? Defining the Challenges in Characterisation and Potential Uses of This Ligandome. International Journal of Molecular Sciences 2021; 22(24) doi: 10.3390/ijms222413554
|
| 47 |
Nazila Hajiahmadi, Mathias Tenbusch, Somayeh Shatizadeh Malekshahi, Atefeh Yari, Seyed Mohammad Moazzeni, Taravat Bamdad. Dendritic cells targeted CEA tumor antigen through DEC205 in combination with oncolytic reovirus stimulate strong immune response in colorectal cancer model. Cellular Immunology 2026; 422 doi: 10.1016/j.cellimm.2026.105074
|
| 48 |
Ilene Le, Subramanian Dhandayuthapani, Jessica Chacon, Anna M. Eiring, Shrikanth S. Gadad. Harnessing the Immune System with Cancer Vaccines: From Prevention to Therapeutics. Vaccines 2022; 10(5) doi: 10.3390/vaccines10050816
|
| 49 |
Mengmeng Zuo. Advances in Cancer Vaccines for Colorectal Cancer: Insights from Clinical Trials. Proceedings of the 2025 14th International Conference on Bioinformatics and Biomedical Science 2025; doi: 10.1145/3778067.3778082
|
| 50 |
Sandra Schwarz, Johanna Schmitz, Markus W Löffler, Michael Ghosh, Hans-Georg Rammensee, Evgenia Olshvang, Marvin Markel, Nadine Mockel-Tenbrinck, Andrzej Dzionek, Susann Krake, Basak Arslan, Kapil Dev Kampe, Anne Wendt, Peter Bauer, Christina S Mullins, Andreas Schlosser, Michael Linnebacher. T cells of colorectal cancer patients’ stimulated by neoantigenic and cryptic peptides better recognize autologous tumor cells. Journal for ImmunoTherapy of Cancer 2022; 10(12) doi: 10.1136/jitc-2022-005651
|
| 51 |
Sanjukta Sen, Sreemoyee Mitra, Dipanjan Karati. Targeting drug resistance in colorectal cancer using peptide-based scaffolds: new frontiers in colorectal cancer therapy. Nanomedicine 2026; 21(5) doi: 10.1080/17435889.2026.2628241
|
| 52 |
Zohreh Jahanafrooz, Fatemeh Oroojalian, Ahad Mokhtarzadeh, Abbas Rahdar, Ana M. Díez‐Pascual. Nanovaccines: Immunogenic tumor antigens, targeted delivery, and combination therapy to enhance cancer immunotherapy. Drug Development Research 2024; 85(5) doi: 10.1002/ddr.22244
|
| 53 |
Lynne W. Elmore, Susanna F. Greer, Elvan C. Daniels, Charles C. Saxe, Michael H. Melner, Ginger M. Krawiec, William G. Cance, William C. Phelps. Blueprint for cancer research: Critical gaps and opportunities. CA: A Cancer Journal for Clinicians 2021; 71(2) doi: 10.3322/caac.21652
|
| 54 |
Jiahui Zhang, Jingyi Fan, Mariusz Skwarczynski, Rachel J Stephenson, Istvan Toth, Waleed M Hussein. Peptide-Based Nanovaccines in the Treatment of Cervical Cancer: A Review of Recent Advances. International Journal of Nanomedicine 2022; doi: 10.2147/IJN.S269986
|
| 55 |
Elham Sharif, Leila Nematollahi, Elham Mohit. Immunotherapy Treatment of Colorectal Cancer and Lung Metastasis with Genetically Modified Outer Membrane Vesicles Delivering Poly-Neoepitopes in a Mouse Model. Applied Biochemistry and Biotechnology 2026; 198(7) doi: 10.1007/s12010-026-05646-5
|
| 56 |
Ana Montero-Calle, María Garranzo-Asensio, Maria Teresa Moreno-Casbas, Susana Campuzano, Rodrigo Barderas. Autoantibodies in cancer: a systematic review of their clinical role in the most prevalent cancers. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1455602
|
| 57 |
Qianli Ye, Shixing Liu, Shiqiang Lin, Wen Xie. Circular RNA circSEMA5A facilitates colorectal cancer development by regulating microRNA-195-5p to target CCNE1 axis. Cellular Signalling 2023; 107 doi: 10.1016/j.cellsig.2023.110649
|
| 58 |
Xiaofei Zhang, Qin Hu, Xuesong He, Xinyue Cui, Zhaoyuan Liang, Li Wang, Xiongwei Deng, Ze Zhang, Wang Sheng, Xiaodong D. Han. CD16 CAR-T cells enhance antitumor activity of CpG ODN-loaded nanoparticle-adjuvanted tumor antigen-derived vaccinevia ADCC approach. Journal of Nanobiotechnology 2023; 21(1) doi: 10.1186/s12951-023-01900-8
|
| 59 |
Khin Zay Yar Myint, Masamori Shimabuku, Yoko Shimizu, Junichi Taguchi. Comparison of genomic response among patients receiving dendritic cell vaccines pulsed with two different cancer-associated antigens: A retrospective observational study. Current Research in Translational Medicine 2026; 74(3) doi: 10.1016/j.retram.2026.103593
|
| 60 |
T. Anders Olsen, Kevin J. Barnum, David Avigan, Jacalyn Rosenblatt. Cancer vaccines in hematologic malignancy: A systematic review of the rational and evidence for clinical use. Best Practice & Research Clinical Haematology 2025; 38(3) doi: 10.1016/j.beha.2025.101650
|
| 61 |
Cristina Aparicio, Marina Belver, Lucía Enríquez, Francisco Espeso, Lucía Núñez, Ana Sánchez, Miguel Ángel de la Fuente, Margarita González-Vallinas. Cell Therapy for Colorectal Cancer: The Promise of Chimeric Antigen Receptor (CAR)-T Cells. International Journal of Molecular Sciences 2021; 22(21) doi: 10.3390/ijms222111781
|
| 62 |
|
| 63 |
Alaa Alsalloum, Julia Shevchenko, Sergey Sennikov. The Melanoma-Associated Antigen Family A (MAGE-A): A Promising Target for Cancer Immunotherapy?. Cancers 2023; 15(6) doi: 10.3390/cancers15061779
|
| 64 |
Evangelos Koustas, Eleni-Myrto Trifylli, Panagiotis Sarantis, Nikolaos Papadopoulos, Eleni Karapedi, Georgios Aloizos, Christos Damaskos, Nikolaos Garmpis, Anna Garmpi, Kostas A. Papavassiliou, Michalis V. Karamouzis, Athanasios G. Papavassiliou. Immunotherapy as a Therapeutic Strategy for Gastrointestinal Cancer—Current Treatment Options and Future Perspectives. International Journal of Molecular Sciences 2022; 23(12) doi: 10.3390/ijms23126664
|
| 65 |
Wenjing Cai, Tuyue Sun, Chenyu Qiu, Huixiang Sheng, Ruijie Chen, Congying Xie, Longfa Kou, Qing Yao. Stable triangle: nanomedicine-based synergistic application of phototherapy and immunotherapy for tumor treatment. Journal of Nanobiotechnology 2024; 22(1) doi: 10.1186/s12951-024-02925-3
|
| 66 |
Liu Chuang, Ju Qifeng, Yu Shaolei. The tumor immune microenvironment and T-cell-related immunotherapies in colorectal cancer. Discover Oncology 2024; 15(1) doi: 10.1007/s12672-024-01117-7
|
| 67 |
Wenli Fang, Zhangyan Jing, Yuan Li, Zhirang Zhang, Zhongda Lin, Zhaoxin Yang, Yishi Tian, Chi Zhang, Yumeng Ma, Linlin Hou, Fanqiang Meng, Xin Liang, Xudong Zhang. Harnessing enucleated cancer cells as Trojan horse cell vaccines. Cell Reports Physical Science 2024; 5(1) doi: 10.1016/j.xcrp.2023.101752
|
| 68 |
Liguo Ye, Long Wang, Ji’an Yang, Ping Hu, Chunyu Zhang, Shi’ao Tong, Zhennan Liu, Daofeng Tian. Identification of tumor antigens and immune subtypes in lower grade gliomas for mRNA vaccine development. Journal of Translational Medicine 2021; 19(1) doi: 10.1186/s12967-021-03014-x
|
| 69 |
Liguo Ye, Long Wang, Ji’an Yang, Ping Hu, Chunyu Zhang, Shi’ao Tong, Zhennan Liu, Daofeng Tian. Identification of Tumor Antigens and Immune Landscape in Glioblastoma for mRNA Vaccine Development. Frontiers in Genetics 2021; 12 doi: 10.3389/fgene.2021.701065
|
| 70 |
Sofian Al Shboul, Ashita Singh, Renata Kobetic, David R. Goodlett, Paul M. Brennan, Ted Hupp, Irena Dapic. Mass Spectrometry Advances in Analysis of Glioblastoma. Mass Spectrometry Reviews 2025; 44(4) doi: 10.1002/mas.21912
|
| 71 |
Mahdi Jafarlou, Vahid Jafarlou, Samaneh Nouri, Nazila Alizadeh, Zahra Azimzadeh Tabrizi, Mahsa Iravani, Farid Ghorbaninezhad, Deniz Shakiba, Behzad Baradaran. Immunotherapy resistance in colorectal cancer: therapeutic strategies and biomarker-guided approaches. Cancer Cell International 2026; 26(1) doi: 10.1186/s12935-026-04385-1
|
| 72 |
Yanqing Wang, Da Sun, Victoria Laney, Hong Wang, Li Lily Wang, Zheng-Rong Lu. Challenges and opportunities on achieving an adequate delivery efficiency and immunogenicity with peptide-based anticancer vaccines. Advanced Drug Delivery Reviews 2025; 225 doi: 10.1016/j.addr.2025.115675
|
| 73 |
Romy N. Kuipers, Mark A. J. Gorris, Cristina Bayó, Tom Hofland, Daniel Benítez Ribas, Georgina Flórez Grau, Nicoline Hoogerbrugge, Joaquin Castillo, Francesc Balaguer, Tanya M. Bisseling, Gerty Schreibelt, I. Jolanda M. de Vries. Vaccine strategies for cancer prevention in Lynch syndrome: the potential of dendritic cell-based therapy. Familial Cancer 2026; 25(2) doi: 10.1007/s10689-026-00559-y
|
| 74 |
Zohreh Jahanafrooz, Behzad Baradaran, Jafar Mosafer, Mahmoud Hashemzaei, Tayebeh Rezaei, Ahad Mokhtarzadeh, Michael R. Hamblin. Comparison of DNA and mRNA vaccines against cancer. Drug Discovery Today 2020; 25(3) doi: 10.1016/j.drudis.2019.12.003
|
| 75 |
Kangjia Xiao, Chengxuan Xie, Yi Zhang, Meihua Kang, Yanchun Wang, Qingtian Li, Wenqian Dong, Hao Wang, Huaxing Wei, Yanping Hu, Baolong Wang, Renquan Lu. The value of serum tumor-associated autoantibodies in screening and diagnosis of gastric cancer. Clinica Chimica Acta 2025; 569 doi: 10.1016/j.cca.2025.120167
|
| 76 |
Yange Wang, Chenyang Li, Xinlei Qi, Yafei Yao, Lu Zhang, Guosen Zhang, Longxiang Xie, Qiang Wang, Wan Zhu, Xiangqian Guo. A Comprehensive Prognostic Analysis of Tumor-Related Blood Group Antigens in Pan-Cancers Suggests That SEMA7A as a Novel Biomarker in Kidney Renal Clear Cell Carcinoma. International Journal of Molecular Sciences 2022; 23(15) doi: 10.3390/ijms23158799
|
| 77 |
Palaniyandi Muthukutty, Hyun Young Woo, So Young Yoo. Therapeutic Colorectal Cancer Vaccines: Emerging Modalities and Translational Opportunities. Vaccines 2025; 13(7) doi: 10.3390/vaccines13070689
|
| 78 |
Yanwei Shen, Lu Yu, Xiaoli Xu, Shaojun Yu, Zhuo Yu. Neoantigen vaccine and neoantigen‐specific cell adoptive transfer therapy in solid tumors: Challenges and future directions. Cancer Innovation 2022; 1(2) doi: 10.1002/cai2.26
|
| 79 |
Eirik Høye, Vegar J Dagenborg, Annette Torgunrud, Christin Lund-Andersen, Åsmund A Fretland, Susanne Lorenz, Bjørn Edwin, Eivind Hovig, Bastian Fromm, Else M Inderberg, Victor Greiff, Anne H Ree, Kjersti Flatmark. T cell receptor repertoire sequencing reveals chemotherapy-driven clonal expansion in colorectal liver metastases. GigaScience 2022; 12 doi: 10.1093/gigascience/giad032
|
| 80 |
Charles M. Bowen, Krishna M. Sinha, Eduardo Vilar. Current Trends in Vaccine Development for Hereditary Colorectal Cancer Syndromes. Clinics in Colon and Rectal Surgery 2024; 37(03) doi: 10.1055/s-0043-1770383
|
| 81 |
Shengnan Ren, Dingquan Yang, Yongli Dong, Weidong Ni, Meiqi Wang, Lei Xing, Tong Liu, Wenjia Hou, Weixuan Sun, Haolong Zhang, Zhentao Yu, Yi Liu, Jingrui Cao, Hongbo Yan, Ye Feng, Xuedong Fang, Quan Wang, Fangfang Chen. Protamine 1 as a secreted colorectal cancer-specific antigen facilitating G1/S phase transition under nutrient stress conditions. Cellular Oncology 2023; 46(2) doi: 10.1007/s13402-022-00754-w
|
| 82 |
Saad Ahmed, Muhammad Shayaan Mazhar, Muhammad Fahad Shabbir. Neoantigen-Based Cancer Vaccines: Current Innovations, Challenges and Future Directions in Personalized Immunotherapy. Targeted Cancer Therapy Connect 2024; 1(1) doi: 10.69709/CIConnect.2024.194763
|
| 83 |
A. Moeinafshar, S. Hemmati, N. Rezaei. Immunotherapy in AML: a brief review on emerging strategies. Clinical and Translational Oncology 2021; 23(12) doi: 10.1007/s12094-021-02662-1
|
| 84 |
Elena Tosti, Nityanand Srivastava, Winfried Edelmann. Vaccination and Microbiota Manipulation Approaches for Colon Cancer Prevention in Rodent Models. Cancer Prevention Research 2023; 16(8) doi: 10.1158/1940-6207.CAPR-23-0015
|
| 85 |
Haitao Wang, Rui Tang, Ling Jiang, Yingtian Jia. The role of PIK3CA gene mutations in colorectal cancer and the selection of treatment strategies. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1494802
|
| 86 |
Vladimir Roudko, Cansu Cimen Bozkus, Theofano Orfanelli, Christopher B. McClain, Caitlin Carr, Timothy O’Donnell, Lauren Chakraborty, Robert Samstein, Kuan-lin Huang, Stephanie V. Blank, Benjamin Greenbaum, Nina Bhardwaj. Shared Immunogenic Poly-Epitope Frameshift Mutations in Microsatellite Unstable Tumors. Cell 2020; 183(6) doi: 10.1016/j.cell.2020.11.004
|
| 87 |
Ka Lun Leung, Devika Verma, Younus Jamal Azam, Emyr Bakker. The use of multi-omics data and approaches in breast cancer immunotherapy: a review. Future Oncology 2020; 16(27) doi: 10.2217/fon-2020-0143
|
| 88 |
Huanyou Sun, Wenwen Hu, Yinan Yan, Zichun Zhang, Yuxin Chen, Xuefan Yao, Ling Teng, Xinyuan Wang, Dafei Chai, Junnian Zheng, Gang Wang. Using PAMPs and DAMPs as adjuvants in cancer vaccines. Human Vaccines & Immunotherapeutics 2021; 17(12) doi: 10.1080/21645515.2021.1964316
|
| 89 |
Daniel Sur, Andrei Havasi, Calin Cainap, Gabriel Samasca, Claudia Burz, Ovidiu Balacescu, Iulia Lupan, Diana Deleanu, Alexandru Irimie. Chimeric Antigen Receptor T-Cell Therapy for Colorectal Cancer. Journal of Clinical Medicine 2020; 9(1) doi: 10.3390/jcm9010182
|
| 90 |
Qing Li, Shan Geng, Hao Luo, Wei Wang, Ya-Qi Mo, Qing Luo, Lu Wang, Guan-Bin Song, Jian-Peng Sheng, Bo Xu. Signaling pathways involved in colorectal cancer: pathogenesis and targeted therapy. Signal Transduction and Targeted Therapy 2024; 9(1) doi: 10.1038/s41392-024-01953-7
|
| 91 |
Mahmoud Singer, Jennifer Valerin, Zhuoli Zhang, Zigeng Zhang, Farshid Dayyani, Vahid Yaghmai, April Choi, David Imagawa, Nadine Abi-Jaoudeh. Promising Cellular Immunotherapy for Colorectal Cancer Using Classical Dendritic Cells and Natural Killer T Cells. Cells 2025; 14(3) doi: 10.3390/cells14030166
|
| 92 |
Zheying Zhang, Manman Lu, Yu Qin, Wuji Gao, Li Tao, Wei Su, Jiateng Zhong. Neoantigen: A New Breakthrough in Tumor Immunotherapy. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.672356
|
| 93 |
Shailesh Advani, Scott Kopetz. Ongoing and future directions in the management of metastatic colorectal cancer: Update on clinical trials. Journal of Surgical Oncology 2019; 119(5) doi: 10.1002/jso.25441
|
| 94 |
Guan‐Liang Chen, De‐Xia Kong, Yan Lin. Neo‐Antigen‐Reactive T Cells Immunotherapy for Colorectal Cancer: A More Personalized Cancer Therapy Approach. Global Challenges 2023; 7(11) doi: 10.1002/gch2.202200186
|
| 95 |
Elham Sharif, Navid Nezafat, Elham Mohit. Recombinant ClearColi™-derived outer membrane vesicles as an effective carrier for development of neoepitope-based vaccine candidate against colon carcinoma. International Immunopharmacology 2024; 143 doi: 10.1016/j.intimp.2024.113283
|
| 96 |
Jingjing Song, Yujun Zhang, Chulin Zhou, Jianhao Zhan, Xifu Cheng, Haoyu Huang, Shengxun Mao, Zhen Zong. The dawn of a new Era: mRNA vaccines in colorectal cancer immunotherapy. International Immunopharmacology 2024; 132 doi: 10.1016/j.intimp.2024.112037
|
| 97 |
Xiaoxia Huang, Xi Li, Wei Zhou, Liuyi Huang, Haiqing Zhu, Yuehong Lao, Yanting Jiang, Zhenjia Deng, Yuting Tang, Jian Wang. Tumor-associated antigens are associated with primary Sjögren’s syndrome-related interstitial lung disease and disease activity. Clinical Biochemistry 2025; 137 doi: 10.1016/j.clinbiochem.2025.110927
|
| 98 |
Shiyan Zeng, Li Wang, Wanqin Zeng, Lei Sun. Neoantigens in cancer immunoediting: from mechanisms to personalized vaccines in breast cancer. Frontiers in Cell and Developmental Biology 2026; 13 doi: 10.3389/fcell.2025.1733549
|
| 99 |
Ming Yi, Dechao Jiao, Shuang Qin, Qian Chu, Anping Li, Kongming Wu. Manipulating Gut Microbiota Composition to Enhance the Therapeutic Effect of Cancer Immunotherapy. Integrative Cancer Therapies 2019; 18 doi: 10.1177/1534735419876351
|
| 100 |
Giorgiana Fagarasan, Vlad Fagarasan, Vasile Virgil Bintintan, George Calin Dindelegan. The Role of Tumor-Infiltrating B Lymphocytes in Colorectal Cancer Patients: A Systematic Review of Immune Landscape Evolution. Cancers 2025; 17(18) doi: 10.3390/cancers17182996
|
| 101 |
Tabasum Ali, Ifat Jan, Rabiah Bashir, Ghulam Nabi Bader. Proteomics: A Promising Approach for Cancer Research. 2026; doi: 10.1016/B978-0-443-23908-3.00002-2
|
| 102 |
Alyssa Mauri Cornista, Maria Virginia Giolito, Kristi Baker, Hajar Hazime, Inès Dufait, Jashodeep Datta, Saratchandra Singh Khumukcham, Mark De Ridder, Jatin Roper, Maria T. Abreu, Karine Breckpot, Kevin Van der Jeught. Colorectal Cancer Immunotherapy: State of the Art and Future Directions. Gastro Hep Advances 2023; 2(8) doi: 10.1016/j.gastha.2023.09.007
|
| 103 |
Jenna Cleyle, Marie-Pierre Hardy, Robin Minati, Mathieu Courcelles, Chantal Durette, Joel Lanoix, Jean-Philippe Laverdure, Krystel Vincent, Claude Perreault, Pierre Thibault. Immunopeptidomic Analyses of Colorectal Cancers With and Without Microsatellite Instability. Molecular & Cellular Proteomics 2022; 21(5) doi: 10.1016/j.mcpro.2022.100228
|
| 104 |
Giorgiana Fagarasan, Bogdan Alexandru Gheban, Vlad Fagarasan, Doinita Crisan, Teodora Telecan, Vasile Virgil Bintintan, Radu Ioan Seicean, Alexandra Caziuc, George Calin Dindelegan. B and T Tumor-Infiltrating Lymphocyte Subtypes According to Subsite: A Colon Cancer Immunophenotyping Map. Biomedicines 2025; 13(12) doi: 10.3390/biomedicines13122856
|
| 105 |
Andreia Bufalino. Pathological Basis of Oral and Maxillofacial Diseases. 2025; doi: 10.1002/9781119989233.ch25
|
| 106 |
Abhishek Kumar, Dyumn Dwivedi, Neha Ghosh, Kesavaperumal Gopalakrishnan, Mohamed Rahamathulla, Mohammed Muqtader Ahmed, Chandralekha Nair, Dewang Singh, Randhir Singh, Uddalak Das. iPSC-derived polyvalent vaccines as ontogenetically informed immunogens toward overcoming immune refractoriness in microsatellite-stable colorectal cancer: An emerging frontier in cancer immunotherapy. Molecular Immunology 2026; 198 doi: 10.1016/j.molimm.2026.08.008
|
| 107 |
Anastasia Goloudina, Fabien Le Chevalier, Pierre Authié, Pierre Charneau, Laleh Majlessi. Shared neoantigens for cancer immunotherapy. Molecular Therapy Oncology 2025; 33(2) doi: 10.1016/j.omton.2025.200978
|
| 108 |
Xuan Wang, Jingjiang Lai, Dawei Wang, Keyi Wei, Jing Yang. Immunophenotyping of colon cancer for identification of potential antigens for colon cancer vaccines. Frontiers in Oncology 2025; 15 doi: 10.3389/fonc.2025.1403256
|
| 109 |
Yae Kye, Lokesh Nagineni, Shrikanth Gadad, Fabiola Ramirez, Hannah Riva, Lorena Fernandez, Michelle Samaniego, Nathan Holland, Rose Yeh, Kei Takigawa, Subramanian Dhandayuthapani, Jessica Chacon. The Identification and Clinical Applications of Mutated Antigens in the Era of Immunotherapy. Cancers 2022; 14(17) doi: 10.3390/cancers14174255
|
| 110 |
Hajar Rajayi, Parsova Tavasolian, Alaleh Rezalotfi, Marzieh Ebrahimi. Cancer Stem Cells Targeting; the Lessons from the Interaction of the Immune System, the Cancer Stem Cells and the Tumor Niche. International Reviews of Immunology 2019; 38(6) doi: 10.1080/08830185.2019.1669593
|
| 111 |
Mario Tavakoli, Hasan Raza, Dirin Ukwade, Dexter Nwachukwu, Salimah Mohamed, Saeed Ali. Immune Therapy for Pancreatic and Colon Cancers. 2025; doi: 10.1016/B978-0-443-24742-2.00028-9
|
| 112 |
Wenqin Zhang, Qingfu Zhang, Jiaodi Cai, Jin He, Zhijie Xu, Xiang Chen, Guoqun Chen. Hydrogel-Based Vaccines: A Promising Approach for Cancer Immunotherapy. International Journal of Nanomedicine 2025; doi: 10.2147/IJN.S526305
|
| 113 |
Sang-Hyun Kim, Ha-Eun Park, Seong-Un Jeong, Jun-Hyeok Moon, Young-Ran Lee, Jeong-Ki Kim, Hyunseok Kong, Chan-Su Park, Chong-Kil Lee. Induction of Peptide-specific CTL Activity and Inhibition of Tumor Growth Following Immunization with Nanoparticles Coated with Tumor Peptide-MHC-I Complexes. Immune Network 2021; 21(6) doi: 10.4110/in.2021.21.e44
|
| 114 |
Dajiang Li, Wenjing Shen, Siyu Yang, Hongmei Liu, Xiao Tan, Xinrong He, Jingchao Hao, Xinqiang Yin, Finlay Macrae. Whole‐Exome Sequencing to Screen Personal Neoantigens With High Immunogenicity in Patients With Microsatellite Stability (MSS)–Advanced Colorectal Cancer. Human Mutation 2026; 2026(1) doi: 10.1155/humu/3876230
|
| 115 |
Anping Li, Ming Yi, Shuang Qin, Qian Chu, Suxia Luo, Kongming Wu. Prospects for combining immune checkpoint blockade with PARP inhibition. Journal of Hematology & Oncology 2019; 12(1) doi: 10.1186/s13045-019-0784-8
|
| 116 |
Kun Wang, Tong Zhang, Mingyang Liu, Danyang Wang, Haomiao Zhu, Zhaoyu Wang, Fan Yu, Yonghui Liu, Wei Zhao. Synthesis and immunological evaluation of Mincle ligands-based antitumor vaccines. Chinese Chemical Letters 2023; 34(7) doi: 10.1016/j.cclet.2022.108065
|
| 117 |
Weijie Ma, Brian Pham, Tianhong Li. Cancer neoantigens as potential targets for immunotherapy. Clinical & Experimental Metastasis 2022; 39(1) doi: 10.1007/s10585-021-10091-1
|
| 118 |
Sung-Woo Lee, He Yun Choi, Gil-Woo Lee, Therasa Kim, Hyun-Ju Cho, In-Jae Oh, Sang Yun Song, Deok Hwan Yang, Jae-Ho Cho. CD8+ TILs in NSCLC differentiate into TEMRA via a bifurcated trajectory: deciphering immunogenicity of tumor antigens. Journal for ImmunoTherapy of Cancer 2021; 9(9) doi: 10.1136/jitc-2021-002709
|
| 119 |
Li-Feng Hu, Huan-Rong Lan, Dong Huang, Xue-Min Li, Ke-Tao Jin. Personalized Immunotherapy in Colorectal Cancers: Where Do We Stand?. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.769305
|
| 120 |
Meng-Yan Chen, Chen Wang, Yu-Gang Wang, Min Shi. Adoptive cell therapy in colorectal cancer: Advances in chimeric antigen receptor T cells. World Journal of Gastrointestinal Oncology 2025; 17(7): 106723 doi: 10.4251/wjgo.v17.i7.106723
|
| 121 |
Yuanfang Tan, Huiyuan Chen, Xi Gou, Qiuying Fan, Juanjuan Chen. Tumor vaccines: Toward multidimensional anti-tumor therapies. Human Vaccines & Immunotherapeutics 2023; 19(3) doi: 10.1080/21645515.2023.2271334
|
| 122 |
Aya Y. Al-Kabariti, Munthar Abosaoda Kadhim, Hayjaa Mohaisen Mousa, S. Renuka Jyothi, Priya Priyadarshini Nayak, J. Bethanney Janney, Gurjant Singh, Ashish Singh Chauhan. RNA-based cancer vaccines: mechanisms, clinical progress, and translational challenges. Immunologic Research 2025; 73(1) doi: 10.1007/s12026-025-09725-3
|
| 123 |
Carlos A. Gonzalez-Villarreal, Adriana G. Quiroz-Reyes, Jose F. Islas, Elsa N. Garza-Treviño. Colorectal Cancer Stem Cells in the Progression to Liver Metastasis. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.01511
|
| 124 |
Aaron T. Ciner, Keaton Jones, Ruth J. Muschel, Pnina Brodt. The unique immune microenvironment of liver metastases: Challenges and opportunities. Seminars in Cancer Biology 2021; 71 doi: 10.1016/j.semcancer.2020.06.003
|
| 125 |
Mohammad Roufarshbaf, Nafiseh Esmaeil, Vajihe Akbari. Comparison of four methods of colon cancer cell lysates preparation for ex vivo maturation of dendritic cells. Research in Pharmaceutical Sciences 2022; 17(1) doi: 10.4103/1735-5362.329925
|
| 126 |
Rajasekaran Subbarayan, Dhasarathdev Srinivasan, Ranjith Balakrishnan, Ajeet Kumar, Salman Sadullah Usmani, Nityanand Srivastava. Targeting Signaling Pathways in Solid Tumors - Part C. International Review of Cell and Molecular Biology 2024; 389 doi: 10.1016/bs.ircmb.2024.05.001
|
| 127 |
Else Marit Inderberg, Nand Singh, Robert Miller, Sarah Arbe-Barnes, Henrik K. Eriksen, Berit lversen, Hedvig Vidarsdotter Juul, Jon Amund Eriksen, Karianne Risberg Handeland. Generation of frameshift-mutated TGFβR2-specific T cells in healthy subjects following administration with cancer vaccine candidate FMPV-1/GM-CSF in a phase 1 study. Cancer Immunology, Immunotherapy 2025; 74(4) doi: 10.1007/s00262-025-03969-6
|
| 128 |
Azar Dokht Khosravi, Sakineh Seyed-Mohammadi, Ali Teimoori, Aram Asarehzadegan Dezfuli. The role of microbiota in colorectal cancer. Folia Microbiologica 2022; 67(5) doi: 10.1007/s12223-022-00978-1
|
| 129 |
Harsh Kashyap, Bhawna Rathi, Harkirat Singh, Navkiran Kaur, Shivani Sharda, Amarish Kumar Sharma. In silico design and immunoinformatics evaluation of a multi-epitope vaccine targeting SEPT9 for gastrointestinal adenocarcinomas. BMC Immunology 2026; 27(1) doi: 10.1186/s12865-026-00831-x
|
| 130 |
Jinfeng Chen, Ziqi Jin, Shuqing Zhang, Xiao Zhang, Peipei Li, Heng Yang, Yuting Ma. Arsenic trioxide elicits prophylactic and therapeutic immune responses against solid tumors by inducing necroptosis and ferroptosis. Cellular & Molecular Immunology 2022; 20(1) doi: 10.1038/s41423-022-00956-0
|
| 131 |
Dorothea Plundrich, Sophia Chikhladze, Stefan Fichtner-Feigl, Reinhild Feuerstein, Priscilla S. Briquez. Molecular Mechanisms of Tumor Immunomodulation in the Microenvironment of Colorectal Cancer. International Journal of Molecular Sciences 2022; 23(5) doi: 10.3390/ijms23052782
|
| 132 |
Salima Shebbo, Najat Binothman, Manar Darwaish, Hanan A. Niaz, Rwaa H. Abdulal, Jamilah Borjac, Anwar M. Hashem, Ahmad Bakur Mahmoud. Redefining the battle against colorectal cancer: a comprehensive review of emerging immunotherapies and their clinical efficacy. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1350208
|
| 133 |
Shougen Cao, Wenyu Jia, Yifan Zhao, Heng Liu, Jie Cao, Zequn Li. A recent perspective on designing tumor vaccines for tumor immunology. International Immunopharmacology 2024; 142 doi: 10.1016/j.intimp.2024.113090
|